N
NATURAL ALTERNATIVES INTERNATIONAL INC
NAIICIK 0000787253NasdaqNon-AcceleratedSmaller ReportingMedicinal Chemicals & Botanical ProductsDelawareFY ends Jun 30
Period
FY 2025
Revenue
—
Net Income
$-13.57M
Total Assets
$151.94M
Equity
$68.43M
Shares Out
6.18M
Op. Cash Flow
$5.93M
Business
Natural Alternatives International Inc is a formulator, manufacturer and marketer of nutritional supplements that provides private-label contract manufacturing and related services. It offers vitamins, minerals, herbal and other dietary supplement products in capsules, tablets, chewable wafers and powders, and commercializes beta-alanine raw materials and trademarks including CarnoSyn®, SR CarnoSyn® and TriBsyn™. The company operates two key segments: private-label contract manufacturing and royalty, licensing and raw material sales for beta-alanine. Its products are distributed to customers in the U.S. and internationally through direct sales, e-commerce, retail and direct-sales marketing channels.
Summary from filing dated 2025-09-23
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Net sales | 130 | 114 | 154 | 171 | 179 | |
| Cost of goods sold | 121 | 107 | 136 | 140 | 148 | |
| Gross profit | 9 | 7 | 18 | 31 | 30 | |
| Other selling, general and administrative expenses | 17 | 15 | 15 | 17 | 17 | |
| Settlement of legal proceeding and associated expense | 1 | 0 | — | — | — | |
| Loss from operations | −9 | −9 | 5 | 14 | 14 | |
| Interest income | 168,000 | 176,000 | 33,000 | 0 | 1,000 | |
| Interest expense | −915,000 | −361,000 | −451,000 | −83,000 | −118,000 | |
| Foreign exchange loss | −1 | −652,000 | −658,000 | 118,000 | −1 | |
| Other, net | 7,000 | −93,000 | −82,000 | −55,000 | −21,000 | |
| Total other expense | −2 | −930,000 | −1 | −20,000 | −2 | |
| Loss before income taxes | −11 | −9 | 4 | 14 | 12 | |
| Provision (benefit) for income taxes | 3 | −2 | 1 | 3 | 1 | |
| Net loss | −14 | −7 | 3 | 11 | 11 | |
| Change in minimum pension liability, net of tax | 50,000 | 102,000 | 64,000 | 94,000 | 350,000 | |
| Unrealized loss resulting from change in fair value of derivative instruments, net of tax | −1 | −41,000 | −2 | 2 | 272,000 | |
| Comprehensive loss | −15 | −7 | 740,000 | 13 | 11 | |
| Basic (in dollars per share) | −2.28 | −1.23 | 0.43 | 1.75 | 1.71 | |
| Diluted (in dollars per share) | −2.28 | −1.23 | 0.43 | 1.74 | 1.69 | |
| Basic (in shares) | 6 | 6 | 6 | 6 | 6 | |
| Diluted (in shares) | 6 | 6 | 6 | 6 | 6 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 12 | 12 | 14 | 22 | 32 | |
| Accounts receivable less allowance for credit losses of $0 at June 30, 2025 and June 30, 2024 | 15 | 17 | 7 | 17 | 18 | |
| Inventories, net | 25 | 24 | 30 | 32 | 27 | |
| Income tax receivable | 276,000 | 0 | 305,000 | 67,000 | 1 | |
| Forward contracts | 368,000 | 492,000 | 390,000 | 3 | 0 | |
| Prepaids and other current assets | 7 | 8 | 6 | 2 | 2 | |
| Total current assets | 59 | 62 | 57 | 77 | 80 | |
| Property and equipment, net | 51 | 52 | 54 | 45 | 22 | |
| Operating lease right-of-use assets | 41 | 44 | 20 | 22 | 16 | |
| Deferred tax asset, net noncurrent | 0 | 3 | 355,000 | 0 | 214,000 | |
| Other noncurrent assets, net | 719,000 | 2 | 3 | 3 | 2 | |
| Total assets | 152 | 162 | 134 | 146 | 120 | |
| Accounts payable | 15 | 13 | 8 | 16 | 12 | |
| Accrued liabilities | 3 | 3 | 2 | 3 | 2 | |
| Accrued compensation and employee benefits | 2 | 2 | 2 | 4 | 5 | |
| Customer deposits | 1 | 302,000 | 317,000 | 140,000 | 2 | |
| Short-term liability operating leases | 2 | 1 | 2 | — | — | |
| Forward contracts | 2 | 91,000 | 0 | 634,000 | 814,000 | |
| Income taxes payable | 411,000 | 505,000 | 374,000 | 174,000 | 619,000 | |
| Mortgage note payable, current portion | 305,000 | 296,000 | 312,000 | 302,000 | 0 | |
| Line of credit current | 2 | 3 | 0 | — | — | |
| Total current liabilities | 29 | 23 | 16 | 24 | 22 | |
| Long-term liability operating leases | 46 | 46 | 19 | 21 | 16 | |
| Long-term pension liability | 111,000 | 141,000 | 339,000 | 344,000 | 391,000 | |
| Mortgage note payable, net of current portion | 9 | 9 | 9 | 9 | 0 | |
| Income taxes payable, noncurrent | 0 | 740,000 | 987,000 | 1 | 1 | |
| Total liabilities | 84 | 80 | 45 | 57 | 40 | |
| Commitments and contingencies (Notes D, F, H, J and M) | — | — | — | — | — | |
| Preferred stock; $.01 par value; 500,000 shares authorized; none issued or outstanding | 0 | 0 | 0 | 0 | 0 | |
| Common stock; $.01 par value; 20,000,000 shares authorized at June 30, 2025 and June 30, 2024, issued and outstanding (net of treasury shares) 6,178,213 at June 30, 2025 and 6,200,185 at June 30, 2024 | 93,000 | 93,000 | 91,000 | 89,000 | 88,000 | |
| Additional paid-in capital | 34 | 33 | 31 | 30 | 29 | |
| Retained earnings | 59 | 73 | 80 | 78 | 67 | |
| Treasury stock, at cost, 3,326,693 shares at June 30, 2025 and 3,280,721 at June 30, 2024 | −23 | −23 | −23 | −21 | — | |
| Accumulated other comprehensive loss | −1 | −22,000 | −83,000 | 2 | −561,000 | |
| Total stockholders equity | 68 | 83 | 89 | 89 | 80 | |
| Total liabilities and stockholders equity | 152 | 162 | 134 | 146 | 120 |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 5 | 5 | 4 | 4 | 4 | |
| Deferred income taxes | 4 | −3 | −974,000 | 751,000 | −214,000 | |
| Non-cash lease expenses | 7 | 6 | 3 | 3 | 3 | |
| Non-cash compensation | 977,000 | 1 | 1 | 968,000 | 1 | |
| Pension expense, net of contributions | 81,000 | 46,000 | 81,000 | 83,000 | 163,000 | |
| Loss on disposal of assets | 49,000 | 0 | — | — | — | |
| Accounts receivable | 2 | −10 | 12 | 644,000 | −813,000 | |
| Inventories | −622,000 | 5 | 3 | −5 | 966,000 | |
| Prepaids and other assets | 2 | −2 | −4 | 75,000 | −358,000 | |
| Accounts payable and accrued liabilities | 3 | 5 | −9 | 3 | 2 | |
| Operating lease liabilities | −4 | −3 | −2 | −3 | −3 | |
| Forward contracts | 176,000 | 372,000 | 863,000 | −2 | 1 | |
| Income taxes | −1 | 189,000 | −169,000 | 451,000 | −737,000 | |
| Accrued compensation and employee benefits | 36,000 | −273,000 | −1 | −911,000 | 2 | |
| Net cash provided by (used in) operating activities | 6 | −1 | 7 | 12 | 21 | |
| Purchases of property and equipment | −4 | −3 | −14 | −26 | −5 | |
| Net cash used in investing activities | −4 | −3 | −13 | −26 | −5 | |
| (Payments) Borrowings on line of credit | −2 | 3 | — | 0 | −10 | |
| Repurchase of common stock | −178,000 | −221,000 | −2 | −6 | −4 | |
| Payments on long-term debt | −296,000 | −288,000 | −278,000 | −205,000 | 0 | |
| Net cash (used in) provided by financing activities | −2 | 3 | −2 | 4 | −14 | |
| Net increase (decrease) in cash and cash equivalents | 344,000 | −2 | −8 | −10 | 2 | |
| Income taxes | 323,000 | 463,000 | 2 | 3 | 3 | |
| Interest | 814,000 | 285,000 | 802,000 | 206,000 | 131,000 |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro